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Fork-head associated (FHA) domains are widely found in bacteria, but their cellular functions
remain unclear. Here, we focus on Mycobacterium tuberculosis GarA, an FHA-containing protein
conserved in actinomycetes that is phosphorylated by different Ser/Thr protein kinases. Using var-
ious physicochemical approaches, we show that phosphorylation signiﬁcantly stabilizes GarA, and
that its FHA domain interacts strongly with the phosphorylated N-terminal extension. Altogether,
our results indicate that phosphorylation triggers an intra-molecular protein closure, blocking
the phosphothreonine-binding site and switching off the regulatory properties of GarA. The model
can explain the reported functions of this mycobacterial protein as regulator of glycogen degrada-
tion and glutamate metabolism.
Structured summary:
MINT-6804218: GarA (uniprotkb:P64897) and GarA (uniprotkb:P64897) bind (MI:0407) by isothermal
titration calorimetry (MI:0065)
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction These domains act as phosphorylation-dependent protein–proteinModular protein adaptors act in concert with Ser/Thr/Tyr pro-
tein kinases and phosphatases to setup dynamic signaling cascades
and protein–protein interaction networks [1]. Long believed to be a
distinctive feature of higher eukaryotes, these sophisticated regu-
lation and signaling mechanisms are also emerging as fundamental
features in some bacterial species. This is notably the case for one
of the deadliest human pathogens,Mycobacterium tuberculosis. The
mycobacterial genome [2] revealed the presence of many ‘‘eukary-
otic-like” signaling elements, including several genes coding for
Ser/Thr protein kinases and phosphatases [3] as well as various
proteins containing fork-head associated (FHA) domains [4,5].
FHA domains are protein modules composed of 100–120 resi-
dues folded into a characteristic 11-strand beta-sandwich fold.chemical Societies. Published by E
CD, circular dichroism; DLS,
calorimetry; FHA, Fork-head
LS, multi-angle light scatter-
-TOF, surface-enhanced laser
, Mataojo 2020, Montevideo,interaction modules that preferentially bind to phospho-threonine
residues in their targets and seem to be particularly prevalent in
proteins involved in cell cycle control [6], although their molecular
functions are still poorly understood. Here, we focus onM. tubercu-
losis GarA, a protein that is highly conserved in mycobacteria and
corynebacteria, but totally absent in eukaryotes. M. tuberculosis
GarA is a 162-residues protein harboring a C-terminal FHA domain
preceded by an N-terminal peptide extension of about 50 residues
(Fig. 1). GarA was found to be the optimal substrate of the Ser/Thr
protein kinase PknB in mycobacterial protein extracts [7], and both
GarA and its Corynebacterium glutamicum ortholog, OdhI (82% se-
quence identity), were shown to be phosphorylated by protein
kinase PknG [8,9]. In both cases, the protein is speciﬁcally phos-
phorylated on a single Thr residue in a highly conserved ETTS motif
at the middle of the N-terminal peptide extension (Fig. 1).
We report here the effect of GarA phosphorylation on the phys-
ico-chemical and structural properties of the protein. Our results
point to a mechanism by which phosphorylation at the ETTS motif
induces an intra-molecular shutdown of the regulatory properties
of the protein, through a tight self-recognition of the phosphory-
lated N-terminal extension by the C-terminal FHA domain. The
ensuing model is consistent with, and can account for, the appar-
ent functional promiscuity of GarA in actinomycetes [8–10].lsevier B.V. All rights reserved.
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Fig. 1. Modular organization ofM. tuberculosis GarA, composed of a C-terminal FHA
domain and an N-terminal peptide extension including the phosphorylatable ETTS
motif (corresponding to positions 20–23), which is highly conserved in GarA
homologs from actinomycetes. Protein kinase PknB phosphorylates Thr22 and PknG
phosphorylates Thr21.
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2.1. Production of proteins and peptides
The gene encoding M. tuberculosis GarA was cloned into the
pDEST17 expression vector (Invitrogen). Transformed Escherichia
coli BL21(DE3)-pLysS cells were grown in HDM2 medium in
70 ml micro-fermentors, ﬁrst at 30 C until a OD600 nm of 20, then
for 16 h at 14 C after addition of 1 mM IPTG (ﬁnal OD600 nm be-
tween 60 and 70). The C-terminal FHA domain of GarA (GarAD43,
comprising residues 44–162) was cloned into the pET-28A(+) vec-
tor (Invitrogen) using T4 DNA ligase (Biolabs). Transformed E. coli
BL21(DE3)pLysS cells were grown in LB medium supplemented
with kanamycin and chloramphenicol, ﬁrst at 30 C until a
OD600 nm = 0.8 was reached, then for 16 h at 14 C after addition
of 1 mM IPTG.
In both cases, the cells were harvested by centrifugation,
resuspended in buffer A (25 mM HEPES, 500 mM NaCl, 20%
glycerol, 1 mM DTT, 20 mM imidazole, pH 8.0) supplemented
with Complete Protease Inhibitor Cocktail (Roche), and lysed at
4 C with an EmulsiFlex C5 high-pressure homogenizer (Avestin).
The supernatant was cleared by centrifugation and passage
through a Minisart 0.2 lM ﬁlter (Sartorius). The proteins were
ﬁrst puriﬁed by metal-afﬁnity chromatography on a nickel-
loaded HisTrap HP column (GE Healthcare). Protein-containing
fractions were dialysed against buffer B (25 mM HEPES,
100 mM NaCl, 5% glycerol, 1 mM DTT, pH 8.0), and the His6 tag
was removed by incubation for 24 h at 18 C in the presence of
His6-tagged TEV endoprotease at a 1:70 ratio followed by separa-
tion on Ni-NTA agarose column (Qiagen). The untagged recombi-
nant proteins were then further puriﬁed by size-exclusion
chromatography on a Superdex 75 column (GE Healthcare) equil-
ibrated in buffer B. All concentrations were determined by UV/
visible spectrophotometry and amino acid analysis after 6 N
HCl hydrolysis, using a norleucine standard.
Two HPLC-puriﬁed peptides of sequence SDEVTVETTSVFRADFL,
containing either a Thr or a phosphoThr residue at the central po-
sition (in bold), were obtained from Thermo Electron Corporation
(Ulm, Germany). The lyophilized peptides were dissolved in
25 mM HEPES, 100 mM NaCl, pH 8.0, and their concentration was
adjusted to 250 lM.2.2. Phosphorylation assays
To obtain monophosphorylated GarA (GarApT22), the protein
(250 lM) was incubated with M. tuberculosis Ser/Thr protein ki-
nase PknB (15 lM) for 5 h at 30 C in buffer B supplemented with
5 mM MgCl2 and 0.5 mM ATP. The completeness of phosphoryla-
tion was assessed by controlling that the GarA band was totally
shifted upwards in a 15% acrylamide SDS–polyacrylamide gel elec-
trophoresis (PAGE) gel, and that a single peak corresponding to
phosphorylated GarA was detected by mass spectrometry
(surface-enhanced laser desorption ionization time-of-ﬂight
(SELDI-TOF), Ciphergen Bio-Rad).2.3. Limited proteolysis
GarA (180 lg/ml) was incubated with papain (0.45 lg/ml), elas-
tase (1.4 lg/ml), or endoproteinase Glu-C (1.25 lg/ml) for 90 min
at 25 C. The buffer used was 10 mM phosphate, pH 7.0 (papain,
endo-GluC) or 50 mM HEPES, pH 8.0 (elastase). Proteolysis was
stopped with 1 mM iodoacetamide (papain) or 1 mM PMSF (elas-
tase, endoGlu-C), and the reaction products analysed by SDS–PAGE.
N-terminal peptide sequences were determined by Edman deg-
radation on an Applied Biosystems 473A sequencer. The molecular
mass of the fragments was determined by SELDI-TOF spectrome-
try, after adsorption on an H4 reverse phase ProteinChip Array
(Ciphergen Bio-Rad).
2.4. Analytical ultracentrifugation (AUC)
Experiments were conducted at 25 C in a ProteomeLab XL-I
analytical ultracentrifuge (Beckman–Coulter) equipped with an
interference optical detection system. For sedimentation velocity
experiments, protein samples (57, 19 and 6.3 lM, in 25 mMHEPES,
100 mM NaCl, pH 8.0) were spun at 50000 rpm for 4 h, using an
AnTi50 eight-hole rotor and 1.2 cm path-length double-sector alu-
minium center pieces. Interference fringe displacement proﬁles
were monitored at 1-min intervals, and data were analyzed with
the SEDFIT software (www.analyticalultracentrifugation.com),
using a model for continuous sedimentation coefﬁcient distribu-
tion c(s) with deconvolution of diffusional effects. Distributions
were calculated with maximum entropy regularization at a prede-
termined conﬁdence level of one standard deviation.
For sedimentation equilibrium experiments, protein samples
(75, 25 and 8.3 lM in 25 mM HEPES, 100 mM NaCl) were sequen-
tially spun at 18000, 24000 and 30000 rpm. After reaching equi-
librium at each speed (typically after 18 h), 10 successive scans
were recorded and the protein radial distributions were globally
analyzed with the Origin7 (OriginLab) and SEDPHAT softwares.
2.5. Multi-angle light scattering (MALS)
Protein samples (25 lM in 25 mMHEPES, 100 mMNaCl, pH 8.0)
were injected onto a Biosuite 125 HPLC size-exclusion column
(Waters) connected with a DAWN-EOS multi-angle light scattering
detector and an OptilabRex refractometer (Wyatt). The HPLC col-
umn and the detectors were equilibrated at 25 C in the sample
buffer at a ﬂow rate of 0.5 ml/min. The detector responses were
calibrated and normalized by measuring the signal for monomeric
bovine serum albumin. A value of 0.185 ml/g was assumed for the
refractive index increment (dn/dc) of the protein.
2.6. Dynamic light scattering (DLS)
Photon correlation experiments were performed at 25 C with a
DynaPro MS800 instrument (Wyatt). For each sample (25 lM in
25 mM HEPES, 100 mM NaCl, pH 8.0), the total light scattered at
an angle of 90 was collected using a 10 s averaging acquisition
time. Particle translational diffusion coefﬁcients (DT) were calcu-
lated from the autocorrelated light intensity data and converted
to hydrodynamic radii (RH) with the Stokes–Einstein equation. Dis-
tribution plots of intensity versus RH were done with the SEDFIT
software.
2.7. Circular dichroism (CD)
CD spectra were measured with an Aviv 215 spectropolarimeter
(Aviv Biomedical). Far-UV CD spectra were acquired at 25 C using
a cylindrical cell with a 0.02 cm path-length. The samples
(0.36 mg/ml in 25 mM phosphate, 100 mM NaF, pH 8.0), were
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200 nm (0.5 nm step) with an averaging time of 1 s per step, the
second from 200 to 178 nm (0.5 nm step) with an averaging time
of 4 s per step. Both regions were scanned consecutively three
times. The individual spectra from the two regions were merged
and the resulting three data ﬁles were averaged. The spectra, cor-
rected using buffer baselines measured under the same conditions,
were normalised to the molar peptide bond concentration and
path-length (1 cm) as mean molar differential extinction coefﬁ-
cient per residue (De). Secondary structure estimations were de-
rived using the CONTIN/LL method included in the CDPro software.
Near-UV CD spectra were measured between 350 and 250 nm,
with a constant 0.5 nm step and 1 s per step averaging time, using
a 1 cm path-length rectangular cell (proteins at 1.5 mg/ml in
25 mM HEPES, 100 mM NaCl, pH 8.0). Each protein spectrum was
corrected by the corresponding averaged buffer background signal
and normalised to the molar concentration of peptide chain.
Thermally induced unfolding of protein samples (20 lM in
25 mM phosphate, 100 mM NaF, pH 8.0) was monitored in a cuv-
ette with an 0.2 cm path-length by following the change in CD sig-
nal at 215 nm over a temperature range of 25–90 C, with a heating
rate of 0.75 C/min. The curves were ﬁtted with a two-state model
using previously described equations [11].
2.8. Differential scanning calorimetry (DSC)
Endotherms were measured using a VP-DSC calorimeter (Mic-
roCal). Samples (40 lM in 25 mM phosphate, 100 mM NaF, pHFig. 2. Analysis of GarA (gray lines) and GarApT22 (black lines) by AUC, DLS and CD. (A
experiments. (B) Hydrodynamic radius distributions obtained from DLS experiments. (C)8.0) were degassed under vacuum for 10 min with gentle stirring
prior to loading into the calorimetric cell (0.5 ml). After equilibra-
tion for 30 min at 25 C, the samples were heated over a tempera-
ture range of 25–90 C at a constant rate of 0.7/min. After
subtracting a buffer-reference thermogram, the resulting excess
heat capacity curves were analyzed using a two-state model with
the Origin7 software (OriginLab).
2.9. Isothermal titration calorimetry (ITC)
GarAD43 and the synthetic peptides were diluted in 25 mM
HEPES, 100 mM NaCl, pH 8.0 and thoroughly degassed. GarAD43
(15 lM in the 1.4 ml cell) was then titrated at 25 C by 5 ll injec-
tions of peptide (250 lM in the syringe), using a VP-ITC calorime-
ter (MicroCal). Raw data were normalized and corrected for heats
of dilution of the peptides. Binding stoichiometries, enthalpy val-
ues and equilibrium dissociation constants were determined by ﬁt-
ting the corrected data to a bimolecular interaction model using
the Origin7 software (OriginLab).
3. Results and discussion
3.1. Phosphorylation has little effect on the overall structure of GarA
The radial distributions obtained by AUC sedimentation/diffu-
sion equilibrium studies could be optimally ﬁtted using a single-
ideal species model, yielding buoyant molecular masses of 16813
(±633) Da for GarA (theoretical MW: 17176) and 17278) Sedimentation coefﬁcient distributions obtained by sedimentation velocity AUC
Far-UV CD spectra of the two proteins. (D) Near-UV CD spectra of the two proteins.
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The MALS experiment further conﬁrmed these results, as both
forms of the protein were eluted from the HPLC column as single
peaks with virtually the same time retention and static light scat-
tering plateaux corresponding to a molecular mass between 16500
and 17500 Da. Thus, the above studies showed that GarA behaves
as a monomer in solution, and that protein phosphorylation does
not change the oligomerization state of the protein.
We then asked whether phosphorylation could promote a
detectable change of protein shape or conformation. The sedimen-
tation coefﬁcient distributions obtained using analytical centrifu-
gation showed that only one species is present for each protein
(Fig. 2A). Likewise, hydrodynamic radial distributions from quasi-
elastic light scattering experiments showed a single species in each
case, centered around a value of 2.6 nm for GarA and 2.2 nm for
GarApT22 (Fig. 2B). The narrower peaks for the phosphorylated form
of the protein in sedimentation velocity experiments indicate a less
polydisperse, more compact shape, suggesting that phosphoryla-
tion may result in a loss of intrinsic ﬂexibility of the protein.
The far-UV (178–250 nm) CD spectra of the protein, with a deep
minimum in the 200–210 nm region conﬁrmed that GarA con-
sisted principally of b-sheets (Fig. 2C). Deconvolution of the spectra
showed that GarA contained approximately 7% a–helix, 30% b-
sheet, and 24% b-turn, with 39% of the residues belonging to struc-
turally undeﬁned regions. Upon phosphorylation, a slight blueshiftFig. 3. (A) Temperature-induced denaturation of GarA (gray lines) and GarApT22 (black
papain of GarA (left) and GarApT22 (right).and deepening of the minimum, as well as a sharpening of the
maximum around 190 nm, was observed, which is consistent with
a moderate increase in the content of secondary structure (9% a–
helix, 34% b-sheet) at the expense of structurally undeﬁned regions
(34%). Furthermore, the near-UV (250–350 nm) CD spectra showed
marked maxima and minima, indicating that most aromatic resi-
dues of the protein are positioned in well-structured tertiary envi-
ronments (Fig. 2D). This observation is in agreement with a 3D
homology model of the protein, based on the structure of the
FHA domain of M. tuberculosis EmbR [12] as template. The only
Tyr residue in the GarA sequence and 6 (out of 8) Phe residues
are found within the C-terminal FHA domain. Furthermore, phos-
phorylation of GarA induced only small changes of the spectra,
suggesting that the local structural environments of the aromatic
residues are not signiﬁcantly modiﬁed by phosphorylation.
3.2. GarA phosphorylation signiﬁcantly increases the thermal stability
of the protein
Although the above studies indicate only moderate effects of
PknB phosphorylation on the overall structure of GarA, the thermal
stability of the protein was remarkably inﬂuenced by phosphoryla-
tion. The temperature-induced unfolding of GarA and GarApT22 was
studied using CD and DSC. In all cases, the melting proﬁles cor-
rectly ﬁt a simple two-state transition. Most interestingly, thelines) as measured by CD (left) and DSC (right). (B) Time-dependent proteolysis by
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niﬁcant increase (>15 K) in the melting temperature of GarA
(Fig. 3A). The calorimetric enthalpies DH of unfolding are
70.4 ± 0.4 kcal mol1 for GarA and 109.6 ± 1.7 kcal mol1 for Gar-
ApT22. Assuming a DCp value of 2.44 kcal mol1 K1 [13], the esti-
mated free energies of unfolding (DG) are, respectively
2.8 kcal mol1 and 6.5 kcal mol1. Furthermore, a comparable in-Fig. 4. (A) ITC characterization of the interaction between GarAD43 and a GarA-derived sy
(right) states. The phosphorylated peptide binds GarAD43 with a Kd of 0.385
TDS = 4.08 ± 0.42 kcal mol1). (B) Proposed model of GarA as a phosphorylation-depe
binding site and the N-terminal peptide extension accessible for interaction with signalin
recognition (right), effectively blocking the FHA binding site and switching off the regulcrease in melting temperature was observed when GarA was phos-
phorylated by PknG on Thr21 (data not shown), indicating that
phosphorylation of either Thr residue within the ETTS motif pro-
duces a similar protein stabilization effect.
The small effects of phosphorylation on the structural core of
the FHA domain (Fig. 2) suggest that thermal stabilization might
be primarily associated with the structuring of the N-terminalnthetic peptide centered on Thr22 in its unphosphorylated (left) and phosphorylated
(±0.033) lM in an enthalpy-driven reaction (DH = 12.83 ± 0.48 kcal mol1,
ndent molecular switch. The unphosphorylated protein (left) has both the pThr-
g partners. Phosphorylation at a threonine within the ETTS motif then promotes self-
atory functions of the protein.
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vations lend strong support to this hypothesis. First, digestion of
unphosphorylated GarA by three different proteases under mild
conditions quickly produced smaller fragments of the protein, in
all cases with the cleavage sites within the N-terminal extension,
indicating a high accessibility of this region to proteases (Fig. 3B).
As determined by peptide sequencing, endoGluC cleaved GarA
after residues Glu20 and Glu32, while both elastase and papain
treatments generated a single major fragment of 12.5 kDa, which
starts at Ala44 and corresponds roughly to the C-terminal FHA do-
main. In contrast, phosphorylation signiﬁcantly protected GarA
against proteolysis by papain and endoproteinase Glu-C, as virtu-
ally no cleavage could be seen under the same experimental condi-
tions over a time period of 90 min (Fig. 3B).
Secondly, we constructed a recombinant protein lacking the N-
terminal region and including only the FHA fragment as deﬁned by
proteolysis, which corresponds to residues 44–162 of GarA
(GarAD43). The unfolding parameters of GarAD43 were measured
by DSC and found to be very similar to those of full-length GarA
(Tm = 328.9 ± 0.8 K, DH = 73.6 ± 2.7 kcal mol1), suggesting that
the folding stability of unphosphorylated GarA originates largely
in the well-structured FHA domain, with the N-terminal extension
playing a marginal role in maintaining the overall structure of the
protein.
3.3. Phosphorylation promotes self-recognition
Biochemically characterized FHA modules are known to bind
pThr-containing peptides and proteins [14,15]. This is also the case
for GarA, since we have previously demonstrated that the associa-
tion of GarA with both PknB and PknG strongly depends on the
phosphorylation state of these protein kinases, with their pThr res-
idues acting as secondary docking sites for substrate recruitment
[7,9]. Moreover, important residues for pThr-binding in FHA do-
mains (such as Arg81, Ser95 and Arg96) are also highly conserved
in GarA homologs from actinomycetes [7]. These observations
strongly suggest that structuring of the N-terminal extension upon
phosphorylation may involve the self-recognition of the phosphor-
ylated N-terminal segment by the C-terminal FHA domain of GarA.
To validate this self-recognitionmodel,wemeasured the interac-
tion of GarAD43 with two synthetic 17-residue peptides (either
phosphorylated or unphosphorylated at Thr22) corresponding to
theN-terminal region ofGarA and centered on the phosphorylatable
threonine. As expected, only the phosphorylated peptide is able to
bind GarAD43 with a 1:1 stoichiometry (experimental value
0.985 ± 0.025) and a submicromolar afﬁnity,whereas no interaction
could be detected under the same experimental conditions for the
unphosphorylated peptide (Fig. 4A). These experiments clearly
demonstrate that the FHA domain of GarA binds its own N-terminal
peptide extension, but only when the latter is phosphorylated, sug-
gesting that unphosphorylatedGarA (i.e.with a vacant pThr-binding
site) could interactwith otherphosphorylatedproteins, besides pro-
tein kinases, as part of its cellular function(s).
3.4. Biological implications
The physico-chemical and structural studies described above
lend strong support to a model of GarA acting as a molecular
switch in phosphorylation-dependent regulation mechanisms.
Importantly, GarA is a substrate not only of different protein ki-
nases, but also of the M. tuberculosis protein phosphatase PstP
in vitro (data not shown). Although in our hands the GarA dephos-
phorylation reaction is not as efﬁcient as in the case of PstP-med-
iated dephosphorylation of PknB [16], genetic studies have
recently shown that dephosphorylation of OdhI, the GarA homolog
in C. glutamicum, is indeed catalyzed by ppp, the corynebacterialPstP homolog [17], thus indicating that GarA/OdhI can undergo
reversible phosphorylation in vivo.
According to our model, the unphosphorylated form of the pro-
tein displays a structurally ﬂexible N-terminal peptide and a free
pThr-binding site, both of which are accessible for interaction with
(and modulation of) other proteins (Fig. 4B). The phosphorylation
of the N-terminal extension of GarA by PknB at Thr22 (or PknG
at Thr21) would then promote the tight intra-molecular interac-
tion between the N-terminal pThr-containing region and the FHA
domain, thus effectively switching off the regulatory function(s)
of the protein. The phosphorylated N-terminal extension of GarA
should outcompete other phosphorylated proteins for binding to
the FHA domain due to the combined effect of: (1) a relatively high
(submicromolar) binding afﬁnity of the FHA domain for the sepa-
rate N-terminal phosphopeptide (as shown in Fig. 4A), and (2) a
higher effective local concentration because these two interaction
partners are covalently linked in a single polypeptide.
Previous work demonstrated thatM. smegmatis GarA is involved
in the regulation of glycogen accumulation during the exponential
phase of bacterial growth [10]. More recently, it was reported that
C. glutamicum OdhI binds to and inhibits OdhA, the E1o subunit of
2-oxoglutarate dehydrogenase in the TCA cycle [8]. The inhibition
is relieved when OdhI is phosphorylated by PknG, indicating that
OdhI regulates glutamate production in corynebacteria [17]. We
obtained similar results in mycobacteria, where the unphosphory-
lated form of GarA was found to bind and modulate not only the
enzymatic activity of the OdhA homolog, a-ketoglutarate decar-
boxylase, but also that of a large NAD+-speciﬁc glutamate dehydro-
genase [9]. Our proposed self-recognition model can explain these
observations, because GarA was found to interact with its down-
stream partners only in its unphosphorylated form [9]. More gen-
erally, recent studies of bacterial phosphoproteomes tend to
conﬁrm the presence of a signiﬁcant number of proteins that are
phosphorylated at Ser/Thr at some point in their functional cycle
[18–20]. Since many of these phosphoproteins could be the target
of the GarA FHA domain, it could therefore be expected that forth-
coming functional studies will unveil additional regulatory func-
tions of GarA/OdhI acting as a phosphorylation-dependent
molecular switch in actinomycetes.
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